In focus
Latest feed
A New Dawn for Multiple Myeloma Patients: FDA Approves Bristol-Myers Squibb's Zenbexus
Bristol Myers Squibb Shuts Down Houston R&D Lab, Affecting 125 Local Jobs
A New Chapter for Psoriatic Arthritis: Bristol Myers Squibb's Sotyktu Wins Key FDA Approval
Bristol Myers Squibb Announces Significant Operational Shift in Devens, Leading to Job Losses
